Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CBD of Denver Inc. (CBDD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0030-0.0002 (-6.25%)
At close: 03:21PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0032
Open0.0034
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0025 - 0.0035
52 Week Range0.0016 - 0.0188
Volume4,762,610
Avg. Volume10,430,762
Market Cap418,250
Beta (5Y Monthly)3.64
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CBDD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CBD DENVER INC
    Analyst Report: Oracle CorporationOracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • Newsfile

    CBD of Denver Announces First Quarter 2022 Financial Results

    Denver, Colorado--(Newsfile Corp. - May 18, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, filed its first quarter financial statements on OTCMarkets.com for the period ended March 31, 2022.CBD of Denver generated $908,086 revenue in the first three months of 2022, with a net loss of $314,248 ...

  • Newsfile

    CBD of Denver Expands into Europe's Largest Cannabis Market

    Denver, Colorado--(Newsfile Corp. - May 3, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a distributor of CBD and unique CBD products sold in Switzerland and throughout Europe, is pleased to announce its expansion into the German medical cannabis market with the hiring of Bijan Hezarkhani to lead CBD of Denver's growth in this fast growing European market. Bijan has extensive experience in the cannabis industry, including building out a medical ...

  • Newsfile

    CBD of Denver Reports Record $23.5 Million Revenue in 2021

    Company filed audited financial statements for fiscal year 2021 on April 15, 2022 Denver, Colorado--(Newsfile Corp. - April 21, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a manufacturer of CBD oil and unique CBD products sold in Switzerland and throughout Europe, is pleased to announce it filed audited financial statements for fiscal year 2021 on April 15, 2022 reporting a record $23.5 million ...

Advertisement
Advertisement